Sacral nerve stimulation is an implanted device therapy that sends mild electrical pulses to the sacral nerves near the base of your spine, changing how your bladder and bowel communicate with your brain. It’s used when medications and behavioral therapies haven’t resolved overactive bladder, urinary retention, or fecal incontinence. The treatment is sometimes called sacral neuromodulation, and it works through a small, pacemaker-like device placed under the skin in the upper buttock area.
How It Works
The sacral nerves, particularly the one labeled S3, carry signals between your pelvic organs and your brain. In conditions like overactive bladder, those signals become disorganized. Your brain may receive false “full bladder” alerts, or your pelvic floor muscles may not relax properly when you need to urinate. Sacral nerve stimulation corrects this by modulating the nerve signals themselves, not by directly controlling the bladder or bowel muscles.
The device works primarily on sensory nerve fibers, the ones that carry information from your organs up to your spinal cord and brain. For overactive bladder, the electrical pulses interrupt overactive signals that tell your brain the bladder is full when it isn’t. This reduces urgency and frequency. For urinary retention (the inability to fully empty the bladder), the stimulation relaxes the pelvic floor muscles and urethra, making it easier to start and complete urination.
The mechanism for bowel control is similar. The device stimulates sensory fibers from the anal sphincter, rectum, and pelvic floor. This calms overactive nerve signals during rectal filling and strengthens the internal anal sphincter’s resting tone, giving you better control over bowel movements. Throughout all of this, you retain the ability to urinate and have bowel movements voluntarily. The device modulates the reflex pathways rather than overriding them.
Conditions It Treats
Sacral nerve stimulation is FDA-approved for three main conditions:
- Overactive bladder: urgency, frequency, and urge incontinence that haven’t improved enough with medications or pelvic floor therapy.
- Non-obstructive urinary retention: difficulty emptying the bladder when there’s no physical blockage causing the problem.
- Fecal incontinence: involuntary loss of stool that hasn’t responded to dietary changes, medications, or other conservative treatments.
The therapy is also used in some neurogenic bladder conditions, including those caused by multiple sclerosis or spinal cord injury, where abnormal nerve activity disrupts normal voiding patterns. It sits in the treatment hierarchy as a step beyond first-line options. You’d typically try behavioral changes, pelvic floor exercises, and medications before being considered a candidate.
The Two-Stage Process
One of the most distinctive features of sacral nerve stimulation is that you get a trial run before committing to a permanent implant. The process happens in two stages.
In the first stage, a thin wire (called a lead) is placed near the S3 sacral nerve through a small incision in the upper buttock. This lead connects to an external device you wear on a belt under your clothes. The trial period typically lasts two to four weeks, during which your stimulation settings are adjusted every few days to find the best combination. You’ll track your symptoms in a diary throughout.
To move forward with a permanent implant, you generally need at least a 50% improvement in your symptoms during the trial. In some cases, patients with less than 50% improvement but meaningful quality-of-life gains may still proceed if the results meet their personal expectations. If the trial doesn’t help, the lead is simply removed with no lasting effects.
What Permanent Implantation Looks Like
If the trial succeeds, the second stage is implanting the permanent device. You’ll lie face down under local anesthesia. The surgeon enlarges the small incision from the trial, places the permanent neurostimulator (a small battery-powered device) in the upper buttock, and connects it to the lead wire targeting the sacral nerve. The whole procedure takes 40 to 60 minutes.
Once implanted, the device runs continuously, though you can adjust settings or turn it on and off with a handheld remote control. Most people feel a mild tingling or pulsing sensation near the tailbone or pelvic area, which fades into the background over time.
How Well It Works
Success rates are strong, particularly for fecal incontinence. In a long-term follow-up study, 82.7% of fecal incontinence patients had at least a 50% reduction in involuntary bowel episodes after one year. That number held up well over time: 76.1% still had that level of improvement at five years, and 78.6% at seven years.
For overactive bladder and urinary retention, the trial phase itself acts as a reliable predictor. Because you test the therapy before committing to the implant, people who proceed to permanent implantation have already demonstrated meaningful symptom relief. This built-in screening step means that the permanent implant population tends to have high satisfaction rates.
Risks and Complications
A meta-analysis found that fewer than 25% of patients experience any adverse event after permanent implantation. The most common issues are relatively minor:
- Loss of effectiveness over time: 4.7% of patients
- Infection at the implant site: 3.6%
- Pain at the implant site: 3.2%
- Lead migration (the wire shifts out of position): 3.2%
- Uncomfortable stimulation sensations: 2%
Lead migration is rare but notable because it’s the second most common reason for needing a follow-up surgery. When the wire shifts, the electrical pulses no longer reach the correct nerve, and symptoms return. Repositioning or replacing the lead typically resolves the problem.
Battery Life and MRI Considerations
Two main device types are currently available, and they differ significantly in battery life and MRI compatibility.
Recharge-free devices (like the InterStim II) are the traditional standard. They last roughly five to seven years before the battery depletes and the device needs surgical replacement. These devices are currently approved only for head MRI scans, which limits your imaging options if you develop other health issues.
Rechargeable devices (like the Axonics system) are smaller, with an estimated battery life of around 15 years. They also offer conditional safety for full-body MRI, which is a meaningful practical advantage. You’ll need to recharge the device periodically by holding a small charging unit against your skin, typically for about an hour a few times per month.
The choice between the two involves tradeoffs: recharge-free devices mean zero maintenance but more frequent replacement surgeries and limited MRI access. Rechargeable devices require regular charging but last roughly twice as long and allow broader MRI compatibility. Your doctor will help determine which option fits your lifestyle and medical needs.
Living With the Device
After implantation, most people return to normal activities within a few weeks. The device is small enough that it’s not visible through clothing. You’ll carry a patient programmer, a small remote that lets you adjust stimulation intensity or turn the device off when needed.
Periodic follow-up visits are necessary to fine-tune your settings, especially in the first few months. Over time, some people need adjustments as their body adapts to the stimulation. A small percentage (around 4.7%) eventually experience a decline in effectiveness that may require reprogramming or, in some cases, lead revision. The device is fully reversible: if it stops working or you no longer need it, the entire system can be removed.